Skip to content

INNOVA/6 GP SARL

INNOVA/6 GP SARL is a Series C+ and buyout fund in central-europe, eastern-europe and poland writing $56M–$167M checks into Fintech, Healthcare, business-services, tmt, manufacturing, consumer-products, consumer-services and retail.

Not currently making new investments (as of June 13, 2026).

Stages
Series C+, buyout
Sectors
Fintech, Healthcare, business-services, tmt, manufacturing, consumer-products, consumer-services, retail
Check size
$56M–$167M
Invests in
central-europe, eastern-europe, poland
Round role
Leads rounds
Actively investing
No
Founded
2017
Assets under management
$379M

Thesis

The fund targets medium-sized companies with an enterprise value between EUR 50 million and EUR 150 million. Its investment strategy involves both founder succession deals, where Innova Capital takes a majority stake and partners with founders, and 'Platform+' consolidation, which merges companies to leverage synergies for further add-on acquisitions. The fund's geographic scope is primarily Central and Eastern Europe. Target sectors include financial and business services, TMT, manufacturing, consumer products and services, healthcare, and retail. The fund reached a final close at EUR 271 million (approximately $301 million USD) and is considered fully invested. The fund was established around 2017-2018.

Common questions

Does INNOVA/6 GP SARL invest at the Series C+ stage?

Yes. INNOVA/6 GP SARL lists Series C+ and buyout among the stages it invests in.

What check size does INNOVA/6 GP SARL write?

INNOVA/6 GP SARL writes $56M–$167M checks.

Where does INNOVA/6 GP SARL invest?

INNOVA/6 GP SARL invests in central-europe, eastern-europe and poland.